Quamed

28/04/2026

How is Artificial Intelligence (AI) shaping your work today, and how could it support you better?

QUAMED, in partnership with Bee Skilled, is launching an initiative to design a practical, real-world AI learning experience specifically for pharmaceutical and supply chain professionals like you.

To ensure this programme is relevant, useful, and grounded in your daily challenges, we are inviting you to share your input through a short survey.

Your responses will directly influence the topics covered, the case studies demonstrated, and how this program would support your day-to-day work and decision-making.

In this survey, you will help us understand:

- How you currently use (or do not use) AI in your work
- Where you feel confident, and where you need support
- The most valuable areas for AI training in your context
- Your interest in participating in a structured AI masterclass

Duration: Takes just 5–6 minutes | Fully anonymous and confidential

Start the Survey Now - AI in the Pharmaceutical Supply Chain: Member Needs Assessment Survey – Fill out form

https://forms.office.com/pages/responsepage.aspx?id=MF1WutN4Ik2BWibf1Tlli7p2qzNXubBIgI4yhrcgFqBUM0NQOFZBNFZQWk9WSjExUklaRUZDMDQ2Ni4u&route=shorturl

This is an opportunity to co-create a training programme designed around your needs, not assumptions.

We truly value your perspective and hope you will take a few minutes to contribute.

21/04/2026

For the month of March, we conducted a wide range of GSDP and GMP audits, MQAS audits, remote GSDP technical visits, and CAPA plan assessments across Africa, Europe, and Asia. It has been another dynamic and impactful month, reinforcing our commitment to strengthening quality assurance systems across regions.

We are particularly pleased to see continued growth in our Quality Certification Programme (QCP). Notably, one manufacturer approached us to apply for a QCP audit after finding that a previous Quamed GMP audit report not only helped improve their internal processes but also increased their visibility and access to new clients.

17/04/2026

The World Health Organization (WHO) AMR Surveillance and Quality Assessment Collaborating Centres Network, established in 2016, has significantly contributed to global antimicrobial resistance (AMR) surveillance and capacity-building. It has grown from 18 to 36 centres across 20 countries by 2025, supporting the Global Antimicrobial Resistance Surveillance System (GLASS) through the development of standards, capacity-building, and technical guidance. Despite its achievements, the network faces challenges such as limited geographical representation, lack of dedicated funding, and gaps in diagnostic infrastructure, particularly in low- and middle-income countries. To maximise its impact, the network must expand membership, improve output tracking, and advocate for sustainable financing while integrating AMR activities into broader health system strengthening initiatives. The network serves as a model for addressing global health challenges through collaboration, technical expertise, and strategic alignment.

Read more:

16/04/2026

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium.

Read more: https://www.tandfonline.com/doi/full/10.1080/20523211.2026.2649302

15/04/2026

South Africa is making a bold move to locally produce lenacapavir, a groundbreaking twice-yearly HIV prevention injection developed by Gilead Sciences, with support from Unitaid and United States Pharmacopeia (USP), a step that could transform access, strengthen Africa’s pharmaceutical independence, and accelerate the fight to end HIV on the continent by bringing production closer to those most affected.

Read more: https://unitaid.org/news-blog/south-africa-launches-bid-to-enable-local-production-of-long-acting-hiv-prevention-drug-lenacapavir/

Unitaid and Jhpiego welcome the Government of Kenya’s US$7.8 million commitment to scale up lifesaving care for mothers and newborns

11/04/2026

Over two years since IMRES was awarded the QUAMED MQAS QCP certificate on 8 December 2023, recognising a sustained commitment to quality, transparency, and responsible practices. A journey that reflects consistency, trust, and dedication to doing things right.

03/04/2026

3,600 learners. 138 countries. One platform.

In 20 months since its launch, the QUAMED Learning Platform has reached health professionals across the globe, from Kenya and the DRC to Bangladesh and Yemen, all working to ensure people have access to quality-assured medical products.

What keeps them coming back? Our learners said it best:

- "The course helped me develop skills I apply directly in my work."
- Over 95% reported acquiring new knowledge or skills.
- 87% have concrete plans to put those skills into practice.

Whether you work in warehouse management, procurement, NGOs, Ministries of Health, or regulatory agencies, there is a course built for you.

Ready to join thousands of professionals raising the standard of pharmaceutical supply chains?

Enroll here: https://learning.quamed.org/

18/03/2026

The International Society to Improve Use of Medicines has announced that its next global conference will take place in Kathmandu, Nepal from 19–21 November 2026, bringing together experts, researchers, and practitioners dedicated to improving the quality use of medicines worldwide. Building on the momentum of the previous conference in Chiang Mai in 2023, the 2026 edition will provide a platform to share experiences, present research, and collaborate on practical strategies to promote responsible medicine use.

Key discussions will explore digital technologies for medication management, evidence-based guidelines, patient adherence, affordability, and innovative policy implementation. Abstract submissions are now open, offering professionals the opportunity to showcase their work and contribute to global efforts to improve how medicines are used across health systems.

12/03/2026

With the support of Phillips Pharma Group, QUAMED continues to advance quality-assured pharmaceutical procurement across Africa. To date, five distributors that are part of the Phillips Pharma Group have successfully received the Quality Certified Procurement (QCP) certificate.

In Tanzania:

Phillips Pharmaceuticals (Tanzania) Ltd.
Phillips Distributors (T) Ltd.

In Uganda:

Phillips Pharmaceuticals (Uganda) Limited
Star Pharmaceuticals Limited

In Zambia:

Phillips Pharmaceuticals (Zambia) Limited

QUAMED will soon launch four additional QCP certification processes with Phillips Pharma Group distributors in Ghana, Nigeria, Rwanda and Kenya, further strengthening reliable access to quality-assured medicines.

To find more about our QCP certificates: https://quamed.org/quality-certification-program/

10/03/2026

On Monday, 9 March, Quamed’s Director, Ed Veerke, had the opportunity to present Quamed’s activities to the Director-General of the African Medicines Agency, H.E. Dr. Delese Mimi Darko and her team.

During the meeting, we discussed Quamed’s ongoing regulatory system capacity building and support to several African countries, including French speaking NRAs, our GMP and GSDP audits and assessments, and our database containing more than 600 assessment reports, frequently used and referred to by various procuring entities. We also presented the Quamed Learning online platform available for free to regulatory and industry experts to build GSDP capacity, and, last but not least, our Quality Certification Programme.

The discussions highlighted the common areas for strategic collaboration between Quamed and the AMA, and we look forward to further exploring these opportunities together.

09/03/2026

During a visit to Goma, Democratic Republic of Congo, QUAMED’s Executive Director had the opportunity to visit the warehouses of Asrames asbl. As recalled by its Director, Gaston Nyamambichi, the organization has been a member of QUAMED since the very beginning of the network.

ASRAMES began working on the concept of access to quality medicines already in the mid-1990s. They joined QUAMED when it was still a project hosted by the Institute of Tropical Medicine Antwerp in Antwerp, Belgium.

Despite the many challenges faced in the region since opening its doors in 1995, ASRAMES has built a sustainable model that continues to benefit a growing number of people. Over the years, it has also proven to be a trusted partner for numerous NGOs and international organizations, including the World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

During the visit, QUAMED also participated in a management meeting with ASRAMES leadership, including Board President Waso Misona and board members Dr. Prudence Mitangala and Dr. Jean-Bosco Kahindo. The discussion focused on the QCP certification process and opportunities related to the QUAMED Learning training courses.

06/03/2026

Quamed’s Director had the pleasure of supporting the EAC Regional Centre of Excellence for Vaccines, Immunization and Health Supply Chain Management (RCE-VIHSCM) in the mid-term review of its Strategic Plan (2020–2029).

As part of the process, a three-day multi-stakeholder consultative meeting (2–4 March 2026) brought together experts from EAC Partner States.

The depth of expertise in the room made the discussions extremely valuable and will contribute to strengthening the revised strategic plan for the coming years.

Many thanks to the RCE-VIHSCM and the University of Rwanda teams for the excellent organization and the very welcoming working environment.